{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:21Z","timestamp":1761919521298},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1331\/japha.2012.12511","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T21:02:24Z","timestamp":1330376544000},"page":"289-290","source":"Crossref","is-referenced-by-count":1,"title":["Quadrivalent human papillomavirus vaccine: Updated recommendations for males"],"prefix":"10.1016","volume":"52","author":[{"given":"Chelsie B.","family":"Heesch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Hayney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2012.12511_bb0010","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males: Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2012.12511_bb0020","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0025","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0030","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2012.12511_bb0040","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2012.12511_bb0045","author":"Chandra"},{"key":"10.1331\/JAPhA.2012.12511_bb0050","first-page":"1","article-title":"Youth risk behavior surveillance: United States, 2009","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0055","first-page":"1018","article-title":"National, state, and local area vaccination coverage among adolescents aged 13-17 years: United States, 2009","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0060","first-page":"1","article-title":"Improving influenza and pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventative Services","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/JAPhA.2012.12511_bb0065","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2011-0270","article-title":"Parents' experiences with and preferences for immunization reminder\/recall technologies","volume":"128","author":"Clark","year":"2011","journal-title":"Pediatrics"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115304635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115304635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T13:59:24Z","timestamp":1543154364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115304635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1544319115304635"],"URL":"https:\/\/doi.org\/10.1331\/japha.2012.12511","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}